Quantori

Quantori provides comprehensive scientific informatics, data sciences, and digital solutions for the life sciences and healthcare sectors. We serve numerous global pharmaceutical and healthcare clients, offering deep domain expertise with PhD-level skills for AI and technology projects.

VP of Life Sciences Business

Senior Director Life Sciences 

Saleseqn

Providing consulting services to technology SaaS and Consulting organizations. Focused on data-driven approaches to achieving organizational growth.

Founder

Capgemini Engineering

Tessella now part of Capgemini, offers deep expertise in research and development, data science, and engineering delivers rapid business value from your data, whilst helping you progress towards greater digital maturity.  Leading Hybrid Intelligence N. American Life Sciences business. Building strategic partnerships, defining life sciences go-to-market strategy, growing market share, recruiting, mentoring.

Life Sciences AI Sales Director

IDBS

Turned around and led the North American Commercial team to achieve record US growth before and after the acquisition by Danaher. 
Significantly increased US revenue, and built a high-performing commercial team (12 FTE) to support growth plans. 
Defined and executed North American go-to-market strategy. 
Utilized Danaher Business Systems (DBS) tools and processes to achieve growth targets (data-driven approach)

IDBS is a global provider of innovative enterprise data management, analytics and modeling solutions.

Director of North American Sales

Managed IDBS's Strategic Life Sciences accounts (globally). Exceeded revenue targets.

Strategic Account Executive

Tessella

Providing novel informatics solutions and consultancy to the life sciences sector. Tessella excels at both thinking and doing, solving critical business and technology challenges.

Sales Director. Built US Life Sciences business. Defined and led market engagement to increase revenue in the life sciences vertical. Grew revenues through selling specialized, high-technology solutions, and consulting services.

Global Account Director (Life Sciences)

Massachusetts Biotechnology Council

Director of the life sciences informatics committee. Built a steering group of experts and arranged/facilitated Local breakfast meetings and speakers to highlight innovative work in the science/informatics space. 

Mission: To provide meetings where life science informatics professionals can meet one another, build professional networks, and learn more about the challenges and new developments of significance to informatics in the biotechnology and pharmaceutical industries.

Chairman of the Life Sciences Informatics committee

Responsible for developing and managing an internal business development team targetting the pharmaceutical, biotechnology industries, big science, transport, and oil and gas sectors

Sales Executive

SafePharm Laboratories Ltd

Scientist

I operate at the intersection of strategic leadership and hands-on execution. I build, lead, and scale high-performing sales organizations while maintaining direct engagement with enterprise accounts. By combining team leadership with active account management and business development, I drive growth, strengthen client relationships, and position the business for long-term success.

Over the past 20 years, I’ve:

•	Built, led, and mentored high-performing sales teams in AI and SaaS.
•	Managed global accounts and developed go-to-market strategies that drive adoption.
•	Closed multi-million-dollar enterprise engagements and partnerships across R&D industries 
•	Negotiated strategic agreements that expand revenue and accelerate growth.

I’m also the author of Mastering AI Sales: Essential Knowledge for B2B Professionals, a practical playbook that equips founders, consultants, and sales leaders with frameworks to win complex AI sales.
👆 Now available – click the link in my profile header to get your copy.

My mission goes beyond hitting revenue targets. I align advanced technology with business value,  ensuring organizations don’t just adopt AI, but turn it into measurable growth.

Specialties
•	Building & Scaling Sales Teams
•	Enterprise AI Sales & Stakeholder Management
•	Go-to-Market Strategy (Consulting + Product Hybrid Models)
•	Strategic Partnerships & Revenue Expansion
•	Cross-Functional Leadership & Commercial Alignment

Let’s connect if you’re scaling AI solutions, leading enterprise transformations, or looking to accelerate sales impact in complex markets.

David Walker

Everyone says they’re “doing AI in pharma.”
Few actually make it work.

Because AI in life sciences isn’t just about engineers.
It’s about people who understand the science.

At Quantori, our teams blend computational chemists, data scientists, and AI engineers.
They speak the language of R&D, not just code.

That’s why our clients trust us with AI that impacts real science, not just dashboards.

Curious: What’s the biggest gap you see between AI teams and real-world science?

#Quantori #AI #LifeSciencesAI #MLOps #ScientificComputing #PharmaTech

VP of Life Sciences Business | Leading Enterprise AI Partnerships | Team Builder | Author of Mastering AI Sales | MBA, MSc.

I’ve seen too many R&D teams hit the same wall.
They build amazing models...
then run out of compute, speed, or scalability.

That’s where things fall apart.

At Quantori, we built an end-to-end stack that fixes this:
☁️ Cloud HPC for massive simulations
🤖 MLOps for reliable model ops
🧬 AI frameworks tuned for life sciences

From cloudbursting to multimodal AI, we help teams move fast without losing scientific rigor.

Because in science, performance is essential.

#Quantori #HPC #AIInfrastructure #MLOps #LifeSciencesAI #PharmaTech

90% of sellers treat AI like SaaS.
That’s why 90% of them lose the deal.

SaaS = deployment.
AI = data, trust, and change management.

If the data’s messy, the model fails.
If the buyer doesn’t trust it, the deal dies.

AI sales isn’t about features.
It’s about translation, alignment, proof and building trust.

Different beast. Different playbook.

📘 Mastering AI Sales: Essential knowledge for B2B Professionals breaks it all down → https://a.co/d/4e2S2r6

#AISales #AICommercialization #TrustedAdvisor #EnterpriseAI #GenAI

Open article: Mastering AI Sales Essential Knowledge for B2B Professionals by amazon.com

Mastering AI Sales Essential Knowledge for B2B Professionals

The most powerful currency in AI sales isn’t technology, it’s trust.

AI holds massive promise.
But success depends on one thing:
👉 Becoming the trusted advisor your clients rely on for their toughest challenges.

That’s why one of the most important chapters in my new book is:
📘 “Establishing Trust and Credibility in AI Sales.”

Here’s a quick look inside:
🔑 Be transparent: Show your AI’s strengths and its limits.
🎯 Master your client’s world: Translate AI’s real impact.
💡 Share insight: Become a thought leader, not a vendor.
🤝 Build for the long term: Keep trust growing project after project.

Trust isn’t just a value.
It’s the foundation of every successful AI partnership.

👉 Find your copy here: https://a.co/d/2syW6nw

#AI #AISales #TrustedAdvisor #Credibility #SalesLeadership #ClientRelationships #B2BSales #AIStrategy

Everyone wants AI in production.
Few have the discipline to make it happen.

MLOps isn’t optional anymore.

Without it:
🚫 Models sit idle
🚫 DevOps can’t scale science
🚫 No monitoring. No feedback. No progress

This isn’t a tech issue.
It’s an operational maturity issue.

MLOps is how you turn experiments into impact.

At Quantori, we help life science teams move from proof of concept → production with real MLOps discipline.

Because without it...
your AI isn’t working.

#MLOps #AI #PharmaTech #LifeSciencesAI #Quantori

💡 74% of CEOs say they could lose their job within 2 years if they don’t deliver measurable AI results.

That’s from Dataiku’s new Global AI Confessions Report: CEO Edition, and it perfectly captures the shift we’re seeing across life sciences and pharma.

The message is clear:
The era of “AI exploration” is over.
We’ve entered the era of AI accountability, where strategy, governance, and measurable outcomes define success.

Key insights:
🧠 94% of CEOs believe AI agents could soon advise boards as effectively as humans.
🏁 54% admit competitors already have a stronger AI strategy.
🧬 37% have delayed or abandoned AI projects due to regulatory uncertainty.
⚠️ 94% know employees are already using GenAI tools without approval (“shadow AI”).

For pharma and biotech, the implications are huge:

Translating AI from pilots to platforms is now a C-suite priority.

Governance frameworks, scientific, ethical, and regulatory, need to evolve in step with AI innovation.

Those who build trusted AI frameworks and platforms, not just proofs of concept, will define the next generation of R&D productivity.

📘 Full report by Dataiku and The Harris Poll:
👉 https://lnkd.in/eEUw9HJt

#PharmaAI #LifeSciences #AIinR&D #DigitalTransformation #AIAccountability #QuantoriAI

Open article: Global AI Confessions Report: CEO Edition by pages.dataiku.com

Global AI Confessions Report: CEO Edition

Proud to see our vision for agentic AI in Life Science R&D gaining momentum.
 Q-Scientist is redefining how scientists design, test, and learn — faster than ever.
 Details below 👇

Principal and Chief Scientific Officer at Quantori

The future of Life Science R&D is agentic AI.

The buzz at BioTechX Europe this month was incredible! We were honored to present our vision for scientific acceleration with Q-Scientist, our R&D AI/ML platform.

What is agentic AI, and how does Q-Scientist make it possible? It’s about building powerful, flexible workflows using our Multi-Agent Flow Builder. 

This capability lets scientists:
*Design intuitive, powerful workflows without heavy coding.
*Leverage a knowledge library and life science models tailored for genomics,   proteomics, and drug discovery.
*Significantly speed up time-to-insight across the R&D pipeline.

If you missed our talk, "Q-Scientist: A Tailored AI Ecosystem for Life Science R&D," you can download the slides here: https://lnkd.in/e_pV5jCr
Want a deeper dive? Explore Q-Scientist: https://lnkd.in/edxB7XCp

Huge thanks to my co-presenter Artem Terentyuk and the entire Quantori team for a fantastic week of learning and networking!

#Quantori #BioTechX #DrugDiscovery #Genomics #AIAgents #RDAI #BiotechAI

Open article: Building a Trusted AI Hub for a Leading US Healthcare Center | Quantori by quantori.com

Building a Trusted AI Hub for a Leading US Healthcare Center | Quantori

Arsenal Capital Partners

Leads Arsenal’s digital, data, analytics, and AI strategy for the life sciences and healthcare verticals. Drives the creation of highly valuable, differentiated, innovation-rich, growth companies by providing strategic advice to ACP and its portfolio companies, evaluating acquisition targets, and co-creating new product and service offerings with an emphasis on digital automation, data monetization, and AI enablement.

Director, Digital, Analytics, and AI

Generate Biomedicines

Led multidisciplinary teams across technology, data science, automation, and digital transformation to propel Generate into its next phase of growth and scale. Generate's technology platform combines generative AI with cutting-edge automation and wet-lab science to reprogram human biology and transform the discovery and development of protein therapeutics.

Chief Digital Officer

Pfizer

Responsible for leading the digital strategy and portfolio for Pfizer’s Worldwide Research, Development and Medical organization. Provided stewardship and thought leadership to drive innovative use of data, analytics, and digital technologies to create value and superior experiences for patients, healthcare providers, payers, and Pfizer.

Vice President, Digital, Worldwide Research, Development and Medical

Novartis Institutes for BioMedical Research (NIBR)

Responsible for leading Novartis' global technology organization for its research and early development division (NIBR). Managed an annual budget of ~$260M and a team of ~450 employees accountable for informatics, data science, data management, application development, engineering, infrastructure, information security, and IT operations. Successfully turned around an organization struggling with lack of strategic direction and high employee turnover, regaining the confidence and trust of its team members, customers, and stakeholders. Created a new strategy, reorganized the team to be more product-, user- and data-centric, addressed long-standing security gaps, introduced new high-value capabilities, and provided seamless operational stability and support to NIBR’s ~6,000 users during the Covid-19 pandemic. Within 2 years, reduced voluntary turnover by more than 10 percentage points (from the highest to one of the lowest at NIBR), and improved employee engagement scores by up to 14 percentage points, outpacing the rest of Novartis on every category. Served as a member of NIBR’s senior leadership and Novartis’ digital leadership teams.

Chief Information Officer

Covance

Responsible for the architecture, design, implementation, operation, and support of information technology services, and for establishing an encompassing informatics vision to infuse innovation and strategic differentiation into Covance's product offerings. Recruited a new team, developed a ground-breaking technology platform, created the first software-as-a-service offering in the company’s history, and signed landmark agreements with several major pharmaceutical companies to provide strategic oversight of their entire global portfolio of clinical trials. The platform, known as Xcellerate, integrates, analyzes and visualizes clinical trial data in near real time to mitigate risk, protect patient safety, and drive better and faster clinical trial results. Served as a member of Covance’s Global Operating Committee and the Covance Science Council. Recognized with Computerworld’s 2017 Premier 100 Technology Leaders award, the 2018 Scrip award, the 2016 Fierce innovation award, the 2016 Informa clinical and research excellence award, and the 2015 Covance leadership award, the company’s highest recognition for people, process, and client excellence. Covance is the drug development division of LabCorp, the largest healthcare diagnostics company in the world, with 60,000 employees, operations in 60 countries, and annual revenue in excess of $10 billion. Through its preclinical, clinical, and commercialization services, Covance has helped develop one-third of all prescription medicines on the market today.

Chief Data Officer & Head of Technology Products

Johnson & Johnson

Responsible for providing informatics solutions and data analysis services to pharmaceutical R&D. Led a diverse team of programmers, data architects and system integrators delivering high-performance data management systems, applications, and analytical frameworks to enable data-driven decision making, simplify operational workflows, and improve knowledge management and collaboration. Examples include: 1) a medical review platform to monitor the execution of clinical trials and the performance of clinical sites and investigators; 2) a healthcare analytics platform to provide fast and intuitive access to massive electronic health databases to support outcomes and translational research; 3) a system for tracking adverse event volume and compliance metrics for medical safety; 4) a recipe warehouse to understand the impact of process variables on product quality in pharmaceutical manufacturing; 5) an integrated clinical database and tailored analytics to model disease progression and identify novel biomarkers for Alzheimer’s and other neuropsychiatric disorders; and 6) an e-health platform to improve the design of clinical trials and coordination of care for patients with autism spectrum disorder. Led a parallel team of bioinformatics analysts supporting ongoing therapeutic programs. Managed global cross-functional informatics portfolio and presented informatics capabilities to J&J’s executive leadership and external scientific advisors.

Vice President, Informatics

Responsible for all information management systems for research and early development worldwide, and for setting global information technology strategy and architecture for pharmaceutical R&D. Oversaw the design, development, deployment and support of numerous highly praised enterprise-wide information management systems, including discovery data warehouses, electronic lab notebooks, compound and sample management systems, high-throughput/high-content screening platforms, and advanced data mining, analysis and visualization tools for discovery, clinical, and translational research. Led the development and deployment of a major new global regulatory information management system aimed at harmonizing electronic submissions to the health authorities around the world. Stewarded several transformational organizational initiatives as a member of both the R&D IT and Research Capabilities senior leadership teams. Managed a team of >100 employees and contractors.

Vice President, Information Technology, Research & Early Development

Responsible for the informatics and computer-assisted drug design groups. Led the design and successful deployment of ABCD, a global information management system offering the first unified view of discovery data across the enterprise. Managed software platforms supporting J&J's compound and screening logistics.

Senior Research Fellow & Team Leader, Molecular Design & Informatics

3-Dimensional Pharmaceuticals

Founding member of the scientific staff, responsible for building the company’s informatics and computational drug design capabilities. Recruited and managed the informatics and CADD groups. Conceived, designed, implemented and patented the DirectedDiversity® adaptive drug optimization process control technology, and applied it to 3DP’s internal and collaborative drug discovery efforts. Presented technology capabilities to external investors, collaborators, and scientific advisers. Company had a very successful IPO in 2000 and was acquired by J&J in 2003.

Executive Director, Informatics & CADD

Pfizer (Parke-Davis)

Development of new methods for computational drug design and molecular modeling support for internal drug discovery programs.

Senior Scientist, CADD

Digital / IT / Data Science / AI executive with extensive experience in building and leading diverse information management, software engineering and analytics teams in the healthcare industry. Experienced global leader with proven ability to identify strategic initiatives, align stakeholders, and deliver elegant and workable solutions on time and on budget. Accomplished software architect and information integrator, creator of numerous highly successful enterprise-wide information management systems used by thousands of people around the world. Widely published scientist with extensive public sector advisory work. Entrepreneur and innovator with experience in intellectual property development. Advocate of empowered leadership with a passion for building organizational frameworks that promote collaboration, engagement and connectivity across functional, regional, and cultural boundaries.

taplio

The Battle

David Walker

Dimitris K. Agrafiotis

Followers

Posts

Engagements

Likes

Performance ScoreDavid Walker's LinkedIn Performance

Ready to grow your LinkedIn presence?

taplio

The Battle

David Walker

Dimitris K. Agrafiotis

Followers

Posts

Engagements

Likes

Performance Score.css-goub6s{font-size:var(--chakra-fontSizes-md);font-weight:500;color:var(--chakra-colors-gray-600);display:block;margin-top:var(--chakra-space-1);}David Walker's LinkedIn Performance

Ready to grow your LinkedIn presence?

Performance ScoreDavid Walker's LinkedIn Performance